LGR5 and colorectal carcinoma: Since genetic polymorphism in LGR5 gene was suggested as predictive biomarker for response to FU in CRC patients, variants of LGR5 gene is one factor which might explain this discrepancy between different studies (Szkandera et al., 2015).